Cannabinoids and Osteoporosis

A new approach to the debilitating bone loss disease, osteoporosis, could be on the horizon thanks to research by Andreas Zimmer and Meliha Karsak from the Bonn-based Life & Brain Center in Germany and collaborators in Israel, the UK, and the USA.

The researchers have discovered a regulatory mechanism involved in bone loss linked to a chemical receptor in our bodies with a previously unknown function, which could lead to a new treatment.

Read the complete story in the latest issue of Reactive Reports, chemistry webzine.